Company news
Cambium Bio Ltd news in 2017
Cambium Bio Ltd's news releases, calls and decks from 2017, newest first.
CEO Presentation to 2017 Annual General Meeting
November 2, 2017
Sygenus shows longer lasting effect on pain than morphine
September 25, 2017
Regeneus receives R&D tax incentive refund of $2.6m
August 29, 2017
Appendix 4E Revised
August 22, 2017
US patent allowed for Sygenus for acne
July 9, 2017
RGS to receive milestone payment for successful Phase I
June 20, 2017
Japanese Patent Office to grant key patent for Progenza
May 23, 2017
Positive clinical trial results for Progenza
May 22, 2017
Chinese patent granted on stem cell secretions technology
March 27, 2017
Regeneus receives upfront payment of US$5.5m from AGC
January 22, 2017
Decks in 2017
- Shareholder Meeting (November 2017)
Shareholder meeting · 35 slides · Nov 2, 2017